News
-
-
-
-
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained PSR in the amount of €10.2M secured by commitments amounting to 76.6%
Valbiotis announces the launch of a €10.2M capital increase with 76.6% secured commitments to fuel commercial expansion. The offering includes subscription price at €0.86/share, a discount, and expansion plans in Asia and the Middle East -
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the signing of an exclusive distribution agreement in Qatar, a new milestone in the brand’s expansion in the Middle East
Valbiotis signs exclusive distribution agreement with Al Danah Medical Company in Qatar, expanding presence in the Middle East. Launch of 4 products in 2027
